Innovative Medicines Canada has an effective and engaged Board of Directors that enables member companies to achieve common objectives.
Ronnie W. Miller, Hoffmann-La Roche Limited
Cole Pinnow, Pfizer Canada ULC
Melissa Koomey, Gilead Sciences Canada, Inc.
Jorge Bartolome, Janssen Inc.
Ed Dybka, Ipsen Biopharmaceuticals Canada, Inc.
Rute Fernandes, Takeda Canada Inc.
Brian Heath, Amgen Canada Inc.
Alok Kanti, Bayer Inc.
Christian Macher, Novartis Pharmaceuticals Canada Inc.
Lisa Mullett, Sunovion Pharmaceuticals Canada Inc.
Tracey Ramsay, AbbVie Corporation
Frank Stramaglia, Astellas Pharma Canada, Inc.